The Programme for the Integral, Transversal and Multidisciplinary Management of Aortic Valve Stenosis (MITMEVA) has already ensured that 15 patients1
Cardiology, cardiac surgery, orthopaedic surgery and traumatology, gastroenterology, endocrinology and nutrition, neurology and medical oncology are1
This innovative vascular device represents a substantial improvement in the treatment of the obstructive disease and arterial aneurysms.
Dr. Bàrbara Vidal, cardiologist specialising in cardiac imaging and valvular heart disease The team from the Hospital Clínic Cardiovascular Institu1
Aortic valve stenosis (AVS) is a degenerative disease that causes a narrowing of the heart’s aortic valve. This narrowing prevents the valve from ope1
Thrombosis, especially venous thrombosis, are one of the serious complications that can appear in patients affected by COVID-19. These complications,1
